“…Previous neuropathological findings have shown extensive atrophy of cerebellum, brainstem, basal ganglia, and frontal lobes in SCA2 patients (Estrada, Galarraga, Orozco, Nodarse, & Auburger, 1999;Martin et al, 1994), but these postmortem studies may not well reflect abnormalities in vivo or the central nervous system alteration with the disease progression. Voxel-based morphometry (VBM), a processing technique of magnetic resonance imaging (MRI) that can detect regional morphological changes in the whole brain, has been commonly used to evaluate gray matter (GM) and white matter (WM) volume abnormalities in SCA2 patients (Brenneis, Bosch, Schocke, Wenning, & Poewe, 2003;D'Agata, Caroppo, Boghi et al, 2011;Goel et al, 2011;Hernandez-Castillo et al, 2015;Jacobi et al, 2013;Mercadillo et al, 2014;Nave, Ginestroni, Tessa, Cosottini et al, 2008;Olivito et al, 2018). However, the findings of these studies are variable and conflicting.…”